Liver neoplasms
Clinical trials for Liver neoplasms explained in plain language.
Never miss a new study
Get alerted when new Liver neoplasms trials appear
Sign up with your email to follow new studies for Liver neoplasms, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Replacing the whole liver: a radical bid to outlast colorectal cancer
Cure Not yet recruitingThis study tests whether liver transplantation can extend survival for adults with colorectal cancer that has spread only to the liver and cannot be removed or destroyed by local treatments. About 260 participants aged 18 to 65 will receive a new liver from a deceased or living d…
Matched conditions: LIVER NEOPLASMS
Sponsor: Charite University, Berlin, Germany • Aim: Cure
Last updated Sep 12, 2026 00:00 UTC
-
Can a Heat-and-Freeze treatment plus a vaccine outsmart pancreatic cancer?
Disease control Not yet recruitingThis phase 2 trial is testing a novel combination for people with metastatic pancreatic cancer that has progressed after standard first-line chemotherapy. The approach combines a device that alternately freezes and heats the tumor (multimodal thermal therapy) with a personalized …
Matched conditions: LIVER NEOPLASMS
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug cocktail aims to stop rare liver cancer from coming back
Disease control Not yet recruitingThis study tests whether combining an immunotherapy drug (cadonilimab) with a chemotherapy pill (capecitabine) can prevent a rare mixed liver cancer from returning after surgery. About 75 adults who had their tumor completely removed but are at medium-to-high risk of recurrence w…
Matched conditions: LIVER NEOPLASMS
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New ultrasound could predict chemo success in weeks, not months
Diagnosis Not yet recruitingThis study tests whether a special ultrasound technique, called contrast-enhanced subharmonic ultrasound, can predict if chemotherapy is working for stomach cancer that has spread to the liver. Currently, doctors wait about 2 months for CT or MRI scans to see tumor shrinkage. Thi…
Matched conditions: LIVER NEOPLASMS
Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
New ultrasound could predict chemo success in weeks, not months
Diagnosis Not yet recruitingThis study tests a special ultrasound technique called contrast-enhanced subharmonic ultrasound to see if it can predict whether chemotherapy is working for colorectal cancer that has spread to the liver. Currently, doctors wait about 2 months for CT or MRI scans to see if tumors…
Matched conditions: LIVER NEOPLASMS
Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
AR goggles for surgeons: a new way to remove liver tumors?
Symptom relief Not yet recruitingThis early study tests an augmented reality (AR) system that overlays a tumor's image onto the liver during keyhole surgery. Six adults scheduled for liver tumor removal will participate. The goal is to see if the AR guidance helps surgeons remove tumors more completely and safel…
Matched conditions: LIVER NEOPLASMS
Sponsor: Navari Surgical AB • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
1,000 patients to help unlock secrets of liver surgery recovery
Knowledge-focused Not yet recruitingThis study will follow 1,000 adults who have liver or bile duct surgery at one hospital in Italy. Researchers will track complications, survival, and cancer recurrence for up to 5 years. The goal is to better understand what affects recovery and long-term health after these opera…
Matched conditions: LIVER NEOPLASMS
Sponsor: Azienda USL Toscana Centro • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Blood test may replace scans for liver cancer treatment monitoring
Knowledge-focused Not yet recruitingThis study looks at whether blood tests can predict how well liver cancer responds to a standard treatment called TACE. Researchers will collect blood samples from 60 adults with liver cancer before and after TACE, then compare the results with CT or MRI scans. The goal is to see…
Matched conditions: LIVER NEOPLASMS
Sponsor: University of Belgrade • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC